Stay updated on ASP1517 Intermittent Dosing in Peritoneal Dialysis Clinical Trial
Sign up to get notified when there's something new on the ASP1517 Intermittent Dosing in Peritoneal Dialysis Clinical Trial page.

Latest updates to the ASP1517 Intermittent Dosing in Peritoneal Dialysis Clinical Trial page
- Check2 days agoChange DetectedThe record for the completed ASP1517 Phase 3 study is displayed, including its eligibility criteria, treatment arms, outcome measures, and participant data-sharing plan.SummaryDifference59%

- Check9 days agoChange DetectedThe site footer revision label changes from v3.7.2 to v3.8.0; the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedAn NIH-wide notice about website changes and terminology appears above the 403 error page. The site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check30 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1, while the study page continues to display a 403 error.SummaryDifference0.2%

- Check51 days agoChange DetectedData-sharing and transparency-related sections were removed from the study record, including the IPD sharing URL, IPD sharing plan and criteria, and related notes. The deletions also remove links and descriptions for the CSR, SAP, and the full study protocol.SummaryDifference19%

- Check58 days agoChange DetectedRevision updated from v3.6.6 to v3.7.0, indicating a new build of the site's interface. The change represents an underlying software update rather than changes to visible content or user-facing features.SummaryDifference0.0%

Stay in the know with updates to ASP1517 Intermittent Dosing in Peritoneal Dialysis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASP1517 Intermittent Dosing in Peritoneal Dialysis Clinical Trial page.